Homocysteine, pharmacogenetics, methotrexate exposure and toxicity in children with acute lymphoblastic leukemia.

被引:0
|
作者
Kishi, S
Griener, J
Cheng, C
Das, S
Cook, EH
Pei, DQ
Hudson, M
Rubnitz, J
Sandlund, JT
Pui, CH
Relling, MV
机构
[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
[2] Texas Tech Sch Pharm, Amarillo, TX USA
[3] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3008
引用
收藏
页码:760A / 760A
页数:1
相关论文
共 50 条
  • [1] Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.
    Rocha, JC
    Cheng, C
    Liu, W
    Kishi, S
    Das, S
    Cook, EH
    Sandlund, JT
    Rubnitz, J
    Ribeiro, RC
    Pui, CH
    Evans, WE
    Relling, MV
    BLOOD, 2004, 104 (11) : 50A - 51A
  • [2] Update on MTHFR Pharmacogenetics and Methotrexate Toxicity in Childhood Acute Lymphoblastic Leukemia
    Lopez-Lopez, E.
    Martin-Guerrero, I.
    Ballesteros, J.
    Uriz, J.
    Pinan, M. A.
    Garcia-Miguel, P.
    Navajas, A.
    Garcia-Orad, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S286 - S286
  • [3] Pharmacogenetics of response to glucocorticosteroids in adults with acute lymphoblastic leukemia.
    Jamroziak, Krzysztof
    Balcerczak, Ewa
    Szemraj, Zofia
    Salagacka, Aleksandra
    Grzybowska-Lzydorezyk, Olga
    Cebula, Barbara
    Szemraj, Janusz
    Mirowski, Marek
    Robak, Tadeusz
    BLOOD, 2006, 108 (11) : 737A - 737A
  • [4] Pharmacokinetics of methotrexate in infants with acute lymphoblastic leukemia.
    Thompson, P
    Dreyer, ZE
    Blaney, S
    Berg, S
    Murry, D
    Bomgaars, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P47 - P47
  • [5] Genetic Polymorphisms and the toxicity of antileukemic agents in children with acute lymphoblastic leukemia.
    Kishi, S
    Cheng, C
    Pei, DQ
    Das, S
    Cook, EH
    Hijiya, N
    Rizzari, C
    Rosner, G
    Pui, CH
    Evans, WE
    Relling, MV
    BLOOD, 2004, 104 (11) : 542A - 542A
  • [6] Toxicity associated with high dose methotrexate in children with acute lymphoblastic leukemia
    Sinha, Rupal
    Bansal, Shweta
    Abedin, Sarfraz
    Kapoor, Gauri
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 526 - 526
  • [7] TOXICITY DURING HIGH DOSES OF METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Jovanova, B. Choneska
    Glamochanin, S.
    Martinova, K.
    Antevska, Z. Trajkova
    Kocheva, S.
    Jovanovska, A.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S255 - S255
  • [8] Pharmacogenetics of outcome in children with acute lymphoblastic leukemia
    Rocha, JCC
    Cheng, C
    Liu, W
    Kishi, S
    Das, S
    Cook, EH
    Sandlund, JT
    Rubnitz, J
    Ribeiro, R
    Campana, D
    Pui, CH
    Evans, WE
    Relling, MV
    BLOOD, 2005, 105 (12) : 4752 - 4758
  • [9] Pharmacogenetics of CYP3A5 and effects of corticosteroids in children treated for acute lymphoblastic leukemia.
    Dupont, C
    Medard, Y
    Cave, H
    Vilmer, E
    Jacqz-Aigrain, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P20 - P20
  • [10] Math intervention for children with acute lymphoblastic leukemia.
    Moore, I
    Hockenberry, M
    Kaemingk, K
    ONCOLOGY NURSING FORUM, 2005, 32 (01) : 168 - 168